What You Need to Know about Slack’s IPO

Venture firm Accel is known for making one of the most lucrative start-up bets in history, parlaying an early $12.2 million investment in Facebook into a stake worth over $9 billion at the time of the company’s IPO in 2012.

Seven years later, Accel is enjoying a comparable stretch of success.

The firm is the biggest investor in Slack, owning a 23.8% stake ahead of the messaging app’s upcoming public market debut on Thursday. Based on a reference price of $26 a share provided by the New York Stock Exchange on Wednesday, Accel’s shares are worth about $3.1 billion.

That’s a decade after the firm put $1.5 million into the seed round of a gaming company called Tiny Speck, which later morphed into Slack.

Read the full article at CNBC.

Don’t Stop Here

More To Explore

Market Brief: AI Risks and Fed Minutes Incoming

Market Snapshot Market Pulse: U.S. stocks edged sideways, buoyed by fresh AI chatter that kept tech afloat while industrial sectors shrugged off supply-chain jitters. Bond

AARD: 56% Drop Sparks Urgent Investor Scrutiny!

Overview: Aardvark Therapeutics, Inc. (Nasdaq: AARD) is a clinical-stage biotech focused on therapies for metabolic diseases and Prader-Willi Syndrome (PWS) – a rare genetic disorder

Gene-Editing Goldrush Meets AI and ETF Plays

Opening Recap Market Pulse: Gene-editing fervor rippled through biotech circles after a Mordor Intelligence report flagged double-digit growth in cell line development through 2031. Down